India  

`Not scientifically designed`: Bharat Biotech rejects study that claimed Covaxin less effective than Covishield

Zee News Wednesday, 9 June 2021
The Hyderabad-based COVID vaccine manufacturer also said that it will publish the phase 3 trial data in July and after that, it will be applying for the full licensure of COVAXIN.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News [Video]

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News

Covaxin maker Bharat Biotech has claimed that the vaccine is 77.8% effective overall against Covid-19 after analysing results for its phase 3 trials. Bharat Biotech also claimed that Covaxin provides..

Credit: Oneindia     Duration: 02:13Published
Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News [Video]

Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News

Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 according to data from Phase III trials conducted on 25,800 participants across India. The data was submitted to the..

Credit: Oneindia     Duration: 02:03Published